Searchicon: search

OPTIMMUNE®

(0.2% Cyclosporine, USP)

icon: canine

Product Description

An ophthalmic ointment containing 0.2% cyclosporine for management of chronic keratoconjunctivitis sicca (KCS) and chronic superficial keratitis (CSK) in dogs.

PRODUCT LABEL

Indications

OPTIMMUNE Ophthalmic Ointment is indicated for management of chronic keratoconjunctivitis sicca (KCS) and chronic superficial keratitis (CSK) in dogs.

Features and Benefits

  • The only FDA-approved veterinary cyclosporine ophthalmic product.
  • Achieves therapeutic effect while avoiding systemic toxicity.
  • Sterile, preservative-free formulation reduces the chance of secondary infection and chemical irritation.
  • Shelf life up to 24 months with no refrigeration.

Dosage

For further information including dose rate and complete directions and warnings, please see the Product Label by clicking here

How Supplied

OPTIMMUNE Ophthalmic Ointment is available in a 3.5 g tube, carton of 6.

Important Safety Information

For ophthalmic use in dogs only. The clinical effects of OPTIMMUNE® Ophthalmic Ointment have not been determined in dogs with keratoconjunctivitis sicca (KCS) due to the following conditions: congenital alacrima, sulfonamide usage, canine distemper virus, metabolic disease, surgical removal of the third eyelid gland, and facial nerve paralysis with loss of the palpebral reflex. Safety has not been determined in cases of pre-existing viral or fungal ocular infections, nor in puppies, pregnant bitches, or dogs used for breeding. Withdrawal of OPTIMMUNE® Ophthalmic Ointment therapy resulted in rapid clinical regression indicating the need for long-term continual therapy for almost all cases of chronic KCS. For complete safety information, refer to the product label.